ES2174330T3 - Composicion absorbible que contiene bacterias propionicas susceptible de liberar monoxido de nitrogeno en el tubo digestivo humano o animal. - Google Patents

Composicion absorbible que contiene bacterias propionicas susceptible de liberar monoxido de nitrogeno en el tubo digestivo humano o animal.

Info

Publication number
ES2174330T3
ES2174330T3 ES97952992T ES97952992T ES2174330T3 ES 2174330 T3 ES2174330 T3 ES 2174330T3 ES 97952992 T ES97952992 T ES 97952992T ES 97952992 T ES97952992 T ES 97952992T ES 2174330 T3 ES2174330 T3 ES 2174330T3
Authority
ES
Spain
Prior art keywords
human
composition containing
nitrogen monoxide
release nitrogen
digestive tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97952992T
Other languages
English (en)
Inventor
Edmond Daniel Roussel
Charles Gabriel Legrand
Marc Henri Legrand
Nathalie Roland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STANDA LAB SA
Original Assignee
STANDA LAB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9615977A external-priority patent/FR2764801A1/fr
Application filed by STANDA LAB SA filed Critical STANDA LAB SA
Application granted granted Critical
Publication of ES2174330T3 publication Critical patent/ES2174330T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C19/00—Cheese; Cheese preparations; Making thereof
    • A23C19/02—Making cheese curd
    • A23C19/032—Making cheese curd characterised by the use of specific microorganisms, or enzymes of microbial origin
    • A23C19/0321—Propionic acid bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/61—Propionibacterium
    • A23V2400/617—Freudenreichii

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

UTILIZACION DE BACTERIAS PROPIONICAS PARA LA OBTENCION DE UNA COMPOSICION DE ALIMENTACION CORRIENTE O DE UNA COMPOSICION DIETETICA O MEDICAMENTOSA ABSORBIBLE SUSCEPTIBLE DE LIBERAR CANTIDADES FISIOLOGICAMENTE SIGNIFICATIVAS DE OXIDO NITRICO EN EL TUBO DIGESTIVO HUMANO O ANIMAL.
ES97952992T 1996-12-24 1997-12-23 Composicion absorbible que contiene bacterias propionicas susceptible de liberar monoxido de nitrogeno en el tubo digestivo humano o animal. Expired - Lifetime ES2174330T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9615977A FR2764801A1 (fr) 1996-12-24 1996-12-24 Composition dietetique ou medicamenteuse absorbable renfermant des bacteries propioniques susceptibles de degager des quantites importantes de monoxyde d'azote dans l'intestin humain ou animal
FR9700885A FR2764802A1 (fr) 1996-12-24 1997-01-28 Composition adsorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal

Publications (1)

Publication Number Publication Date
ES2174330T3 true ES2174330T3 (es) 2002-11-01

Family

ID=26233208

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97952992T Expired - Lifetime ES2174330T3 (es) 1996-12-24 1997-12-23 Composicion absorbible que contiene bacterias propionicas susceptible de liberar monoxido de nitrogeno en el tubo digestivo humano o animal.

Country Status (15)

Country Link
EP (1) EP0951290B1 (es)
JP (1) JP2001507015A (es)
KR (1) KR100399362B1 (es)
CN (1) CN1126553C (es)
AU (1) AU5669098A (es)
BR (1) BR9714179A (es)
CA (1) CA2275367C (es)
DE (1) DE69711084T2 (es)
DK (1) DK0951290T3 (es)
ES (1) ES2174330T3 (es)
FR (1) FR2764802A1 (es)
IL (1) IL130619A (es)
PL (1) PL187302B1 (es)
TR (1) TR199901447T2 (es)
WO (1) WO1998027991A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2785809B1 (fr) 1998-11-18 2001-01-12 Gervais Danone Sa Selection et utilisations de souches de bacteries lactiques modulatrices de l'immunite non-specifique
FR2796555B1 (fr) * 1999-07-20 2003-12-19 Standa Lab Sa Utilisation de bacteries propioniques pour la production d'acide propionique et/ou de propionates et, le cas echeant, d'acide acetique et/ou d'acetates au niveau du colon
FR2796554A1 (fr) * 1999-07-20 2001-01-26 Standa Lab Sa Utilisation de bacteries propioniques pour la production d'acide propionique et/ou de propionates et, le cas echeant, d'acide acetique et/ou d'acetates au niveau du colon
AU8484901A (en) 2000-08-11 2002-02-25 David R Whitlock Compositions including ammonia oxidizing bacteria to increase production of nitric oxide and nitric oxide precursors and methods of using same
US20050244382A9 (en) * 2002-01-11 2005-11-03 Whitlock David R Compositions including ammonia oxidizing bacteria and methods of using same
FR2837711B1 (fr) * 2002-03-28 2005-05-06 Agronomique Inst Nat Rech Utilisation de la lactobacillus farciminis pour la prevention ou le traitement de pathologies digestives
EP4219679A3 (en) 2014-04-15 2023-08-09 Aobiome LLC Ammonia-oxidizing nitrosomonas eutropha strain d23
US11225640B2 (en) 2014-04-15 2022-01-18 Aobiome Llc Ammonia oxidizing bacteria for treatment of psoriasis

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3011461C2 (de) * 1980-03-25 1986-10-30 Dr. Madaus & Co, 5000 Köln Verwendung von Propionibakterien
EP0071858A1 (en) * 1981-08-06 1983-02-16 Miles Laboratories, Inc. Silage preservation with propionic acid producing microorganisms
US5096718A (en) * 1982-09-17 1992-03-17 The State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Preserving foods using metabolites of propionibacteria other than propionic acid
JPS61247369A (ja) * 1985-04-23 1986-11-04 Zenkoku Nogyo Kyodo Kumiai Rengokai 乳酒粕の利用法
JPH02290803A (ja) * 1989-05-01 1990-11-30 Yakult Honsha Co Ltd 抗菌性組成物およびその用途
US5632981A (en) * 1992-08-24 1997-05-27 The United States Of America As Represented By The Department Of Health And Human Services Biopolymer-bound nitric oxide-releasing compositions, pharmaceutical compositions incorporating same and methods of treating biological disorders using same
US5658565A (en) * 1994-06-24 1997-08-19 University Of Pittsburgh Of The Commonwealth System Of Higher Education Inducible nitric oxide synthase gene for treatment of disease
FR2700778B1 (fr) * 1993-01-27 1995-04-14 Agronomique Inst Nat Rech Milieu sélectif et procédé pour le dénombrement des bactéries propioniques.
JP3532226B2 (ja) * 1993-03-31 2004-05-31 明治乳業株式会社 腸内細菌が産生するビフィズス菌増殖促進物質及びその利用
KR950002765A (ko) * 1993-07-13 1995-02-16 안기영 여드름 치료제 및 그 제조방법
JP3241500B2 (ja) * 1993-08-09 2001-12-25 明治乳業株式会社 食品保存用抗菌剤
JP3447358B2 (ja) * 1994-02-18 2003-09-16 明治乳業株式会社 ビフィズス菌の生残性改善方法

Also Published As

Publication number Publication date
IL130619A (en) 2003-03-12
EP0951290B1 (fr) 2002-03-13
BR9714179A (pt) 2000-02-29
FR2764802A1 (fr) 1998-12-24
KR100399362B1 (ko) 2003-09-26
PL187302B1 (pl) 2004-06-30
KR20000069709A (ko) 2000-11-25
DE69711084D1 (de) 2002-04-18
CA2275367C (fr) 2005-02-22
CA2275367A1 (fr) 1998-07-02
TR199901447T2 (xx) 1999-11-22
EP0951290A1 (fr) 1999-10-27
IL130619A0 (en) 2000-06-01
JP2001507015A (ja) 2001-05-29
WO1998027991A1 (fr) 1998-07-02
CN1126553C (zh) 2003-11-05
DK0951290T3 (da) 2002-07-08
AU5669098A (en) 1998-07-17
PL334277A1 (en) 2000-02-14
CN1245432A (zh) 2000-02-23
DE69711084T2 (de) 2002-11-07

Similar Documents

Publication Publication Date Title
EP1390049A4 (en) COMPOSITIONS FOR THE TREATMENT OF ANIMAL DISEASES AND SYNDROME
AU3109501A (en) System for organ and tissue preservation and hypothermic blood substitution
DE50102856D1 (de) Kieferknochen-transplantat aus natürlichem knochenmaterial
DE69937562D1 (de) Verbessertes angereichertes blutplättchen wundheilmittel
DE69921746D1 (de) Durchstech-ballonkatheter und medizinisches einführrohr zur benutzung dieses katheters
SE9804390D0 (sv) Absorberande alster
IT1307850B1 (it) Composizione farmaceutica a base di fermenti lattici e carboidratinon assorbibili contenente un sale di calcio ed un sale di alluminio
ES2174330T3 (es) Composicion absorbible que contiene bacterias propionicas susceptible de liberar monoxido de nitrogeno en el tubo digestivo humano o animal.
AR023358A1 (es) Cultivos iniciadores liquidos que tienen una estabilidad de almacenamiento mejorada y su uso
IT1290600B1 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina e alcanoil l-carnitine magnesio fumarato
IT1291134B1 (it) Composizioni solide atte alla somministrazione orale comprendenti una alcanoil l-carnitina magnesio citrato
AU4545597A (en) Biomembrane suitable for use in substitution, reconstruction, induction of angiogenesis, neoformation or regeneration of human or animal organs or tissues
DE59406742D1 (de) Anastomosevorrichtung
ES2065696T3 (es) Composicion farmaceutica.
TR199800597T1 (xx) Papillum ait deri iltihab� tedavisi ve �nlenmesi.
IT1291143B1 (it) Composizioni solide atte alla somministrazione orale comprendenti l-carnitina colina tartrato o una alcanoil l-carnitina colina
HK1025560A1 (en) Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid
AR026988A1 (es) Composicion para mejorar la respuesta proliferativa durante la adaptacion del tracto gastrointestinal y uso en el sindrome de intestino corto
August Outcomes research, nutrition care, and the provider-payer relationship
DE60014899D1 (de) Hygienische absorptionsmittel mit geruchskontrolle
SE9000300D0 (sv) Surgoerande komposition
UA32162A (uk) Пристрій для хронального впливу на біологічні і неживі об'єкти
UA32315A (uk) Спосіб накладання шкірного шва
GB0018989D0 (en) The novel use of medium/long chain fatty acids (carbon chain length 4-16) to preserve and protect human organ function during transplantation,transportation &
FR2764803B1 (fr) Composition absorbable renfermant des bacteries propioniques susceptible de degager du monoxyde d'azote dans le tube digestif humain ou animal

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 951290

Country of ref document: ES